The search for a safe and effective anticoagulation regimen in pregnant women with mechanical prosthetic heart valves

Journal of the American College of Cardiology

Volumn 59, Issue 12, 2012, Pages 1116-1118

  Elkayam, Uri ^a   Goland, Sorel ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b KAPLAN MEDICAL CENTER   (Israel)

Author keywords

low dose oral anticoagulation; pregnancy; prosthetic heart valves

Indexed keywords

ANTICOAGULANT AGENT; ENOXAPARIN; HEPARIN; WARFARIN;

ANTICOAGULANT THERAPY; BRAIN HEMORRHAGE; CENTRAL NERVOUS SYSTEM MALFORMATION; DRUG EFFICACY; DRUG SAFETY; EMBRYOPATHY; FEMALE; FETAL HEMORRHAGE; HEART VALVE PROSTHESIS; HUMAN; INTELLIGENCE QUOTIENT; MECHANICAL HEART VALVE PROSTHESIS; NEUROLOGIC DISEASE; NOTE; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SPONTANEOUS ABORTION; THROMBOSIS;

EID: 84858204158     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.12.018     Document Type: Editorial

References (26)

1. U. Elkayam, H. Singh, A. Irani, M.W. Akhter Anticoagulation in pregnant women with prosthetic heart valve J Cardiovasc Pharmacol Ther 9 2004 107 115 (Pubitemid 39071596)
2. C. McLintock Anticoagulant therapy in pregnant women with mechanical prosthetic heart valves: no easy option Thromb Res 127 2011 56 60
3. W.S. Chan, S. Anand, J.S. Ginsberg Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature Arch Intern Med 160 2000 191 196 (Pubitemid 30054338)
4. K. Kawamata, R. Neki, K. Yamanaka Risks and pregnancy outcome in women with prosthetic mechanical heart valve replacement Circ J 71 2007 211 213 (Pubitemid 46182694)
5. A.A. Al-Lawati, M. Venkitraman, T. Al-Delaime, J. Valliathu Pregnancy and mechanical heart valves replacement; dilemma of anticoagulation Eur J Cardiothorac Surg 2 2002 223 227 (Pubitemid 34831860)
6. S.S. Meschengieser, C.G. Fondevila, M.T. Santarelli, M.A. Lazzari Anticoagulation in pregnant women with mechanical heart valve prostheses Heart 82 1999 23 26 (Pubitemid 29309230)
7. M.A. Geelani, S. Singh, A. Verma, A. Nagesh, V. Betigeri, M. Nigam Anticoagulation in patients with mechanical valves during pregnancy Asian Cardiovasc Thorac Ann 13 2005 30 33 (Pubitemid 40613202)
8. M. Sillesen, V. Hjortdal, N. Vejlstrup, K. Sørensen Pregnancy with prosthetic heart valves30 years' nationwide experience in Denmark Eur J Cardiothorac Surg 40 2011 448 454
9. M.S. Shannon, M.B. Edwards, F. Long, K.M. Taylor, J.P. Bagger, M. De Swiet Anticoagulant management of pregnancy following heart valve replacement in the United Kingdom, 19862002 J Heart Valve Dis 17 2008 526 532
10. L. Sadler, L. McCowan, H. White Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves Br J Obstet Gynecol 107 2000 245 253 (Pubitemid 30081591)
11. M. Cotrufo, M. De Feo, L.S. De Santo Risk of warfarin during pregnancy with mechanical valve prostheses Obstet Gynecol 99 2002 35 40 (Pubitemid 34075465)
12. N. Vitale, M. De Feo, L.S. De Santo Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves J Am Coll Cardiol 33 1999 1637 1641
13. S. Mehndiratta, A. Suneja, B. Gupta, S. Bhatt Fetotoxicity of warfarin anticoagulation Arch Gynecol Obstet 282 2010 335 337
14. V. Regitz-Zagrosek, C. Blomstrom Lundqvist, C. Borghi ESC guidelines on the management of cardiovascular diseases during pregnancy Eur Heart J 2011 Oct 13 [E-pub ahead of print]
15. L.S. De Santo, G. Romano, A. Della Corte Mechanical aortic valve replacement in young women planning on pregnancy: maternal and fetal outcomes under low oral anticoagulation A pilot observational study on a comprehensive preoperative counseling protocol J Am Coll Cardiol 59 2012 1110 1115
16. C. McLintock, L.M. McCowan, R.A. North Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin BJOG Int J Obstet Gynaecol 116 2009 1585 1592
17. H. Koertke, A. Zittermann, O. Wagner Efficacy and safety of very low-dose self-management of oral anticoagulation in patients with mechanical heart valve replacement Ann Thorac Surg 90 2010 1487 1493
18. M. Torella, D. Torella, P. Chiodini Lowering the intensity of oral anticoagulant therapy in patients with bileaflet mechanical aortic valve replacement: results from the LOWERING-IT trial Am Heart J 160 2010 171 178
19. R.O. Bonow, B.A. Carabello, K. Chatterjee 2008 focused update incorporated into the ACC/AHA2006 guidelines for the management of patients with valvular heart disease A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) J Am Coll Cardiol 52 2008 e1 e142
20. J.L. Ecker, F.D. Frigoletto Jr Cesarean delivery and the risk-benefit calculus N Engl J Med 356 2007 885 888 (Pubitemid 46339905)
21. Physicians' Desk Reference 2011 PDR Network Montvale, NJ 3023
22. L.A. Barbour, J.L. Oja, L.K. Schultz A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation Am J Obstet Gynecol 191 2004 1024 1029 (Pubitemid 39298153)
23. E. Friedrich, A.B. Hameed Fluctuations in anti-factor Xa levels with therapeutic enoxaparin anticoagulation in pregnancy J Perinatol 30 2010 253 257
24. J. Fan, S. Goland, N. Khatri, U. Elkayam Monitoring of anti-Xa in pregnant patients with mechanical prosthetic valves receiving low molecular weight heparin: peak or trough levels (abstr)? Circulation 122 2011 A18219
25. U. Elkayam, F. Bitar Valvular heart disease and pregnancy Part II: prosthetic valves J Am Coll Cardiol 46 2005 403 410 (Pubitemid 41040278)
26. Y. Yinon, S.C. Siu, C. Warshafsky Use of low molecular weight heparin in pregnant women with mechanical heart valves Am J Cardiol 104 2009 1259 1263